TargetedResponse

[TargetedResponse @Targeted2022]

🥳🥳🥳
#fondzanauku #TARGRES #programideje #IBISS #MFUB

We are so excited to announce that our new website is now live ✨

Visit it and learn more about the objectives of our project, team members, and more!
https://t.co/MhXIZzkH0k

[TargetedResponse @Targeted2022]

The achievements of IBISS were highlighted through presentations by Dr. Milica Pešić, Dr. Danijela Maksimović-Ivanić, Dr. Aleksandra Uskoković, and Dr. Aleksandra Mladenović, demonstrating their impactful contributions to the biomedical research in Serbia and beyond.

[TargetedResponse @Targeted2022]

Dr. Milica Pešić, the PI of TartetedResponse, attended IBISS Biomedicine Research and Collaboration Capacity at Roche’s RISE Event.

[TargetedResponse @Targeted2022]

Roche's initiative RISE hosted a one-day event in Ložionica, Beograd, on 27 September, aimed at bridging the gap between innovation in clinical practice and collaborative research. The programme featured several sessions tailored for experts in the field.

[TargetedResponse @Targeted2022]

🎙️ We're also proud to highlight the interview with our Principal Investigator, Dr. Milica Pešić, featured in a news portal, where she shared insights about our project’s goals, challenges, and impact.

[TargetedResponse @Targeted2022]

🔙✨ Throwback highlights from #TargetedResponse project!

[TargetedResponse @Targeted2022]

📍 In May 2022, Dr. Miodrag Dragoj completed a short-term scientific mission at the Institute for Cancer Research, Medical University of Vienna, Austria. During his stay (May 4–30), he received specialized training in bioinformatics for DNA sequencing data.

[TargetedResponse @Targeted2022]

📢 The #TargetedResponse team has published a new article in Oncologie, titled ''Impact of ex vivo cell culturing on ABC transporters’ expression and drug sensitivity in patient-derived non-small cell lung cancer models''.

DOI: 10.1515/oncologie-2025-0228

#fondzanauku #IDEJE

[TargetedResponse @Targeted2022]

Coimbra, Portugal, 2022
At The 5th Annual STRATAGEM Meeting, Dr. Miodrag Dragoj shared our vision on how functional diagnostics can revolutionize targeted cancer treatments.(‘’Functional diagnostics as a new concept for the improvement of personalized targeted therapy’’)

[TargetedResponse @Targeted2022]

🔬 Throwback to some of the inspiring scientific meetings where #TargetedResponse team showcased our work!

[TargetedResponse @Targeted2022]

Zagreb, Croatia, 2024
Dr. Ana Podolski-Renić took the stage at The 7th HDIR Meeting, presenting how our research is bringing personalized therapy for NSCLC one step closer to clinical reality. (‘’Functional diagnostics in personalized therapy for non-small cell lung carcinoma’’)

[TargetedResponse @Targeted2022]

paris, France, 2023
Dr. Jelena Dinić represented the team at ESMO Open, presenting our findings on functional diagnostics and ex-vivo drug screening in NSCLC — paving the way for tackling multidrug resistance and advancing personalized therapy.

[TargetedResponse @Targeted2022]

Belgrade, Serbia, 2024
At The 5th Belgrade Bioinformatics Conference (BelBI), Dr. Miodrag Dragoj presented our work on integrating functional diagnostics and bioinformatics for a smarter, more personalized approach to cancer treatment.

[TargetedResponse @Targeted2022]

TargetedResponse team member Ana Stepanović is one of this year's winners of the SDIR award for best publication in cancer research for 2025. Congratulations to Ana!

[TargetedResponse @Targeted2022]

Članica tima TargetedResponse Ana Stepanović je jedna od ovogodišnjih dobitnica SDIR nagrade za najbolju publikaciju u oblasti istraživanja raka za 2025. godinu.
Čestitamo Ani!

#fondzanauku #IDEJE #TargetedResponse #programideje

[TargetedResponse @Targeted2022]

📢 Tim #TargetedResponse objavio je novi članak u časopisu Current Issues in Molecular Biology, koji se fokusira na personalizovani pristup u lečenju nesitnoćelijskog karcinoma pluća.
🔗 Pročitajte ceo članak ovde: https://t.co/JkJjXmFrx3

[TargetedResponse @Targeted2022]

📢 The #TargetedResponse team has published a new article in Current Issues in Molecular Biology, focusing on personalized treatment strategy in non-small cell lung carcinoma (NSCLC).

🔗 Read the full article here: https://t.co/JkJjXmFrx3

[TargetedResponse @Targeted2022]

Member's of the #TargetedResponse team, Dr. Milica Pešić and Dr. Ana Podolski-Renić, presented the project results at ABC2025 conference at Innsbruck.

[TargetedResponse @Targeted2022]

Članice tima #TargetedResponse, dr Milica Pešić i dr Ana Podolski-Renić, prezentovale su deo rezultata projekta na ABC2025 konferenciji u Insbruku.

[TargetedResponse @Targeted2022]

Here are the survey graphics illustrating diversity of participating institutions and the participant composition overview.

[TargetedResponse @Targeted2022]

We would like to express our gratitude to all participants for their valuable collaboration during the #TargetedResponse project webinar. Your contribution and active involvement in the discussions were key to the event's success!